All Stories

  1. Group 2 ILCs: A way of enhancing immune protection against human helminths?
  2. A novel mycobacterial In Vitro infection assay identifies differences of induced macrophage apoptosis between CD4+ and CD8+ T cells
  3. Epidemiology of Mansonella perstans in the middle belt of Ghana
  4. Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
  5. Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
  6. Group 2 Innate Lymphoid Cell Proportions Are Diminished in Young Helminth Infected Children and Restored by Curative Anti-helminthic Treatment
  7. Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children
  8. Down Regulation of the TCR Complex CD3ζ-Chain on CD3+ T Cells: A Potential Mechanism for Helminth-Mediated Immune Modulation
  9. CD16 Expression on Monocytes in Healthy Individuals but Not Schistosome-Infected Patients Is Positively Associated with Levels of Parasite-Specific IgG and IgG1
  10. The microbiota and helminths: sharing the same niche in the human host
  11. Cytokine Responses to the Anti-schistosome Vaccine Candidate Antigen Glutathione-S-transferase Vary with Host Age and Are Boosted by Praziquantel Treatment
  12. Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes
  13. Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoniat the point-of-care in northeast Zimbabwe
  14. Parasite-Derived MicroRNAs in Host Serum As Novel Biomarkers of Helminth Infection
  15. Sources of heterogeneity in human monocyte subsets
  16. Soluble CD23 Levels are Inversely Associated with Atopy and Parasite-Specific IgE Levels but Not with Polyclonal IgE Levels in People Exposed to Helminth Infection
  17. Immunological Consequences of Antihelminthic Treatment in Preschool Children Exposed to Urogenital Schistosome Infection
  18. Chitinase 3-Like 1 Protein Levels Are Elevated in Schistosoma haematobium Infected Children
  19. Integrated Analysis of Innate, Th1, Th2, Th17, and Regulatory Cytokines Identifies Changes in Immune Polarisation Following Treatment of Human Schistosomiasis
  20. Age-Related Patterns in Human Myeloid Dendritic Cell Populations in People Exposed to Schistosoma haematobium Infection
  21. Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium
  22. Chronic Infection Drives Expression of the Inhibitory Receptor CD200R, and Its Ligand CD200, by Mouse and Human CD4 T Cells
  23. Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed toSchistosoma haematobium
  24. Atopy Is Inversely Related to Schistosome Infection Intensity: A Comparative Study in Zimbabwean Villages with Distinct Levels of Schistosoma haematobium Infection
  25. Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria
  26. Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni
  27. Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
  28. Schistosome Infection Intensity Is Inversely Related to Auto-Reactive Antibody Levels
  29. Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
  30. Regulation of triggering receptor expressed on myeloid cells 1 expression on mouse inflammatory monocytes
  31. Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
  32. NKG2D ligands in tumor immunity
  33. 0.2kb promoter sequence of the murine Cyp19 gene target β-galactosidase expression to specific brain areas of transgenic mice